HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Philip A Philip Selected Research

Mammaplasty (Breast Reconstruction)

5/2009Protein kinases C isozymes are differentially expressed in human breast carcinomas.
5/2003Cytochrome p450 and glutathione transferase expression in human breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Philip A Philip Research Topics

Disease

91Neoplasms (Cancer)
05/2022 - 01/2003
64Pancreatic Neoplasms (Pancreatic Cancer)
12/2021 - 08/2002
27Adenocarcinoma
01/2021 - 01/2003
13Neoplasm Metastasis (Metastasis)
02/2022 - 08/2007
7Colorectal Neoplasms (Colorectal Cancer)
10/2021 - 02/2008
7Breast Neoplasms (Breast Cancer)
05/2009 - 11/2002
6Microsatellite Instability
01/2022 - 01/2018
6Hepatocellular Carcinoma (Hepatoma)
10/2013 - 02/2009
5Neuroendocrine Tumors (Neuroendocrine Tumor)
10/2021 - 02/2015
5Stomach Neoplasms (Stomach Cancer)
01/2021 - 02/2003
4Disease Progression
10/2021 - 10/2012
4Carcinogenesis
08/2021 - 01/2003
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2022 - 12/2007
3Primitive Neuroectodermal Tumors (PNET)
10/2021 - 02/2015
3Turcot syndrome
08/2020 - 01/2018
3Rectal Neoplasms (Rectal Cancer)
10/2017 - 08/2007
3Neutropenia
10/2014 - 12/2006
2Colonic Neoplasms (Colon Cancer)
02/2022 - 10/2017
2Cholangiocarcinoma
10/2021 - 01/2018
2Exanthema (Rash)
10/2015 - 07/2006
2Fatigue
10/2014 - 10/2013
2Pathologic Processes
12/2013 - 08/2009
2Liver Neoplasms (Liver Cancer)
05/2012 - 09/2005
2Squamous Cell Neoplasms (Squamous Cell Cancer)
04/2011 - 07/2004
2Fibrosis (Cirrhosis)
11/2009 - 08/2003
2Diarrhea
06/2009 - 07/2006

Drug/Important Bio-Agent (IBA)

36GemcitabineFDA Link
10/2021 - 07/2003
20MicroRNAs (MicroRNA)IBA
06/2021 - 04/2008
13ErbB Receptors (EGF Receptor)IBA
10/2015 - 09/2005
12Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2003
11Erlotinib Hydrochloride (CP 358,774)FDA Link
10/2015 - 09/2005
10NF-kappa B (NF-kB)IBA
05/2010 - 05/2004
9Fluorouracil (Carac)FDA LinkGeneric
01/2019 - 12/2003
8Pharmaceutical PreparationsIBA
01/2021 - 05/2010
8IsoflavonesIBA
01/2013 - 05/2004
7Proteins (Proteins, Gene)FDA Link
05/2022 - 03/2011
6EnzymesIBA
10/2021 - 05/2003
6Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2019 - 06/2009
6Capecitabine (Xeloda)FDA Link
08/2012 - 06/2004
6GenisteinIBA
08/2011 - 05/2004
6Cisplatin (Platino)FDA LinkGeneric
04/2010 - 12/2003
6Docetaxel (Taxotere)FDA Link
10/2007 - 05/2004
5selinexorIBA
05/2022 - 02/2013
5Immune Checkpoint InhibitorsIBA
01/2022 - 01/2018
5Irinotecan (Camptosar)FDA LinkGeneric
01/2021 - 02/2008
5Cetuximab (Erbitux)FDA Link
01/2021 - 08/2010
5130-nm albumin-bound paclitaxelIBA
03/2020 - 01/2019
5Leucovorin (Folinic Acid)FDA Link
01/2019 - 04/2007
5Biological ProductsIBA
10/2015 - 01/2003
5Tyrosine Kinase InhibitorsIBA
10/2015 - 12/2007
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2013 - 11/2009
5Celecoxib (Celebrex)FDA Link
08/2012 - 11/2004
5Cyclooxygenase 2 (Cyclooxygenase-2)IBA
08/2012 - 12/2005
4RNA (Ribonucleic Acid)IBA
01/2022 - 11/2002
4DNA (Deoxyribonucleic Acid)IBA
01/2022 - 03/2011
4p21-Activated KinasesIBA
10/2021 - 01/2017
4Bevacizumab (Avastin)FDA Link
01/2019 - 07/2010
4LigandsIBA
01/2018 - 09/2005
4CurcuminIBA
01/2016 - 05/2010
43,3'-diindolylmethane (diindolylmethane)IBA
01/2013 - 10/2007
4Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
08/2012 - 12/2005
4Carboplatin (JM8)FDA LinkGeneric
11/2009 - 02/2003
3B7-H1 AntigenIBA
01/2022 - 01/2019
3EverolimusFDA Link
10/2021 - 02/2015
3Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
09/2019 - 02/2013
3ParaffinIBA
11/2018 - 08/2012
3Formaldehyde (Formol)FDA Link
11/2018 - 08/2012
3Paclitaxel (Taxol)FDA LinkGeneric
11/2009 - 02/2003
2Complement System Proteins (Complement)IBA
02/2022 - 01/2017
2Poly(ADP-ribose) Polymerase InhibitorsIBA
12/2021 - 11/2020
2rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA
10/2021 - 01/2019
2KPT-9274IBA
10/2021 - 11/2019
2infigratinibIBA
10/2021 - 01/2018
2NAD (NADH)IBA
10/2021 - 11/2019
2pembrolizumabIBA
08/2020 - 01/2018
2TOR Serine-Threonine KinasesIBA
11/2019 - 02/2015
2folfirinoxIBA
10/2019 - 01/2019
2KPT-185IBA
09/2019 - 02/2013
2Exportin 1 ProteinIBA
09/2019 - 10/2017
2Phosphotransferases (Kinase)IBA
01/2018 - 02/2010
2ras ProteinsIBA
01/2018 - 01/2012
2Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
02/2015 - 04/2013
2Sorafenib (BAY 43-9006)FDA Link
10/2013 - 02/2009
2Monoclonal AntibodiesIBA
08/2010 - 01/2010
2thymoquinoneIBA
06/2010 - 01/2010
2Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
05/2010 - 12/2007
2MI 319IBA
05/2010 - 04/2010
2Antineoplastic Agents (Antineoplastics)IBA
02/2010 - 10/2005
2IsoenzymesIBA
05/2009 - 02/2009

Therapy/Procedure

67Therapeutics
05/2022 - 08/2002
17Drug Therapy (Chemotherapy)
10/2021 - 08/2003
9Radiotherapy
01/2019 - 12/2003
6Combination Drug Therapy (Combination Chemotherapy)
01/2019 - 02/2003
4Immunotherapy
01/2022 - 01/2018
3Oral Administration
05/2022 - 05/2010
2Adjuvant Chemotherapy
02/2022 - 01/2020
2Neoadjuvant Therapy
01/2020 - 01/2019
2Induction Chemotherapy
07/2019 - 08/2003
2Precision Medicine
01/2015 - 07/2013
2Mammaplasty (Breast Reconstruction)
05/2009 - 05/2003